Skip to content
  • About Us
  • Contact Us
  • Press Release

The Global News Press

Daily Source of Industry News & Updates !!

  • Top Stories
  • Health
  • Science
  • Technology
  • Press Release
  • Toggle search form
Hepatitis C Drug Market

Rising Cases Of Chronic Disease Is Set To Drive The Global Hepatitis C Drug Market

Posted on March 9, 2021 By Jorge Sipple No Comments on Rising Cases Of Chronic Disease Is Set To Drive The Global Hepatitis C Drug Market

Hepatitis is a medical condition that mainly affects the liver, infecting the digestive system, and the brain in the long run. There are three main types of hepatitis: HAV, HBV and HCV. HCV is a major public health problem that causes inflammation to the liver. Certain medications and excessive alcohol consumption, toxins, bacterial and viral infections can cause hepatitis. Hepatitis C infection can cause acute and chronic hepatitis.

The hepatitis C virus (HCV) spreads in an infected person’s blood using standard needles or medicines used for infusion. Factors such as an increase in the number of injecting drug users, an increase in awareness, an unsatisfactory need and the planned launch of new drugs are likely to contribute to the growth of the market during the forecast period. The market is showing a trend towards pediatric combination vaccines that protect against multiple causative agents and therefore reduce the cost savings associated with packaging and administering individual vaccines.

Earlier in November, 2020, Cadila Healthcare Ltd., also known as Zydus Cadila, declared about its completion of phase two clinical trial of its Hepatitis C drug, ‘PegiHepTM’ on Covid-19 patients.

The global hepatitis C drug market is broadly diversified based on product, disease type, distribution channel, and regions. The global market hepatitis C drugs is also segmented based on product into NS5A Inhibitor, fixed-dose. On the basis of disease type, the global market is bifurcated into acute hepatitis C, and chronic hepatitis C. Further based on distribution channel, the global market is classified into hospital pharmacies, online pharmacies, and retail pharmacies, among others.

Region-wise, North America is anticipated to grow at fast-pace owing to growing patient population. Asia Pacific is foreseen to show the fastest growth amid improvement in healthcare & sanitation, rising awareness about the hepatitis vaccination, and growing access to medicines. Other regional markets such as the Middle East and Africa is on a verge to flourish in the global hepatitis C drug market.

The increase in health care costs, together with the decline in R&D activities and medical budgets, are some of the main factors that influence participants’ profitability and significantly affect market dynamics. The global hepatitis C drug market is majorly driven by leading players through their product offerings and innovation in the relative segment. This participants include Merck & Co, Bristol-Myers Squibb, Roche, AbbVie, Johnson & Johnson, Gilead Sciences, and Basel GlaxoSmith. Increased awareness of the availability of generics is also expected to increase the number of treatments and improve overall health outcomes.

Jorge Sipple
Jorge Sipple
Health, Top Stories

Post navigation

Previous Post: Global Autonomous Tractors Market to Attain US$ 4,723.8 Million by 2025 – ZMR
Next Post: Increased Consumption Of Alcohol In Various Events To Surge Demand In Global Alcohol Ingredients Market

Related Posts

Global Aerospace Materials Market to generate USD 33.7 Billion by 2026 – Market Research Store Digital Journal
Angiography Devices Market Witness Stunning Growth By 2028 – GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Canon Corporation Digital Journal
Point of Care Glucose Testing Market Rise in Demand, Future Analysis by Top Leaders – Nova Biomedical, Trividia Health, Ascensia Diabetes Care Digital Journal
Workplace Transformation Market : Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2027 Top Stories
Global Medical Nonwoven Disposables Market Revenue To Hit US$ 14.67 Billion By 2027 Digital Journal
Global 3D Printing Metals Market Revenue To Hit US$2,321 Million By 2027 Top Stories

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Data recoverers crack Apple’s M1 chip
  • Global Electrosurgical Generators Market Manufacturers and suppliers, Geographical insights and Competitive landscape 2022-2028
  • Global Biometric Payments Market Growth will Accelerate at CAGR value, SWOT Analysis and EBITA Analysis | Know More
  • Global Hyperhidrosis Treatment Market by Historical data, Financial reports of key industry players and Industry journals | Know More
  • Global Robo-Taxi Market by Industry experts, Strategic decision makers, Manufacturers and suppliers and Channel partners|Know More

Who We are

The Global News Press is a news platform that offers a detailed report on every global affair in a unique and conversational way. While we are one of the key news providers all across the world, the enormous number of our followers is the end product of our consistent, true, and trustworthy news reporting service. Besides covering all the happenings around the world only after checking the authenticity of each news report, we see that the platform is not used for the purpose of spreading hatred or propaganda.

Company

  • Home
  • Contact Us

Copyright © 2023 The Global News Press.

Powered by PressBook Grid Blogs theme